Americans Views on Trump Trade and Tariff Policies Draw Mixed Sentiment Pew Survey Indicates JP Morgan Lowers Price Target on Banco Bilbao Vizcaya Argentaria BBVA but Retains Overweight Rating Walmart WMT Selected Among 12 Top Dividend Stocks for Retirement Portfolios Deutsche Bank Lifts Equinix Price Target on Data Center Growth Prospects Elon Musks Lawsuit Against OpenAI and Sam Altman Dismissed as Court Rejects 150B Claim Crypto Middlemen in China Sidestep Crackdown Amid Trade Surge UFP Technologies Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Gains FGNXP Q1 2026 Earnings Massive EPS Surprise on OneTime Gains TrustCo Bank Corp NY Q1 2026 Earnings Steady EPS Amid Quiet Quarter Immatics NV IMTX Q1 2026 Earnings EPS Misses Estimates Stock Rises 5 Amid Pipeline Progress Envela Corporation ELA Q1 2026 Earnings Strong EPS Surprise of 2285 Despite Modest Stock Decline MPT Q1 2026 Earnings EPS Surges Past Estimates with 65 Surprise Illumination Acquisition Corp I Units ILLUU Holds Steady at 999 Amid Quiet Trading Palladyne AI Corp Warrants PDYNW Hover Near Penny Level as Price Dips 244 Aurora Innovation Warrants AUROW Slide 109 as Resistance Caps Recovery at 042 Shift4 Payments FOUR Slips Marginally Tests Key Support Levels Amid Market Caution Gabelli Convertible and Income Securities Fund GCV Gains 154 as Support Holds Steady FTSE 100 Edges Higher as Iran Deal Optimism Tempers Oil Price Surge TNMG Q4 2025 Earnings Massive EPS Miss Stock Climbs 326 Against Expectations JFB Construction Holdings JFB Gains 318 as Shares Test Resistance Near 580 BioXcel Therapeutics BTAI Falls Further as Biotech Struggles to Hold Support NACCO Industries NC Gains 157 as Stock Tests Key Resistance Levels 707 Cayman Holdings Limited JEM Sees Modest Gain Amid Narrow Trading Range AFGE American Financial Group 4500 Subordinated Debentures due 2060 Holds Steady Amid FixedIncome Calm abrdn Global Premier Properties Fund AWP Holds Steady Near Support Amid Sector Uncertainty Li Bang International LBGJ Hovers Near Support Amid Modest Decline Nasus Pharma NSRX Edges Higher Approaches Key Resistance Level